
Andrew R. Branagan, MD, postdoctoral associate in Medicine (Hematology), Yale Cancer Center, discusses the significance of a vaccine developed to better protect patients with multiple myeloma from getting the flu.

Your AI-Trained Oncology Knowledge Connection!


Published: March 29th 2016 | Updated: